Showing 221 - 240 results of 66,470 for search '(((( 2 step decrease ) OR ( 5 ht decrease ))) OR ( 5 ((mean decrease) OR (a decrease)) ))', query time: 1.09s Refine Results
  1. 221
  2. 222
  3. 223
  4. 224
  5. 225
  6. 226

    5.HT<sub>1A</sub> binding difference between known cause of death (KCOD) controls and SIDS. by Hannah C. Kinney (10280975)

    Published 2025
    “…When SIDS is compared to all KCOD controls, the HG, NTS, and MAO show a significant mean difference in 5-HT<sub>1A</sub> receptor binding. …”
  7. 227
  8. 228
  9. 229
  10. 230

    Data_Sheet_1_Determining 5HT7R’s Involvement in Modifying the Antihyperalgesic Effects of Electroacupuncture on Rats With Recurrent Migraine.pdf by Lu Liu (171341)

    Published 2021
    “…<p>Electroacupuncture (EA) is widely used in clinical practice to relieve migraine pain. 5-HT<sub>7</sub> receptor (5-HT<sub>7</sub>R) has been reported to play an excitatory role in neuronal systems and regulate hyperalgesic pain and neurogenic inflammation. 5-HT<sub>7</sub>R could influence phosphorylation of protein kinase A (PKA)- or extracellular signal-regulated kinase<sub>1</sub><sub>/</sub><sub>2</sub> (ERK<sub>1</sub><sub>/</sub><sub>2</sub>)-mediated signaling pathways, which mediate sensitization of nociceptive neurons via interacting with cyclic adenosine monophosphate (cAMP). …”
  11. 231
  12. 232
  13. 233

    Increasing TPP side chain length decreases melanoma cell viability and clonogenic survival. by Kyle C. Kloepping (9928265)

    Published 2020
    “…The error bars for all data presented in Fig 2 represent the mean ± SEM. Results demonstrate that TPP derivatives decrease melanoma cell viability and clonogenic survival; and there is a structure-activity relationship between TPP side chain length and decreased viability and clonogenic survival.…”
  14. 234

    Data_Sheet_1_5-HT1A Receptor Agonist Promotes Retinal Ganglion Cell Function by Inhibiting OFF-Type Presynaptic Glutamatergic Activity in a Chronic Glaucoma Model.docx by Xujiao Zhou (6661499)

    Published 2019
    “…In addition, the high expression of GS and EAAT2 induced by glaucoma was downregulated by the 5-HT1A receptor agonist 8-OH-DPAT and the 5-HT1A receptor antagonist WAY-100635, respectively. …”
  15. 235
  16. 236

    Structure of YOLOv5s-SBC. by Zhongjian Xie (4633099)

    Published 2024
    “…Compared to the original model, P-YOLOv5s-GRNF decreased parameters by 18%, decreased model size to 11.9MB, decreased FLOPs to 14.5G, and increased FPS by 4.3. …”
  17. 237
  18. 238
  19. 239
  20. 240